Thema micronutrient deficiencies

biosyn’s CEO proud about Panama. selenase® T peroral now approved for sale there.

biosyn’s CEO proud about Panama. selenase® T peroral now approved for sale there.

At the beginning of the year, biosyn announced that Panama’s National Department of Pharmacy and Drugs at its Ministry of Health had approved selenase® T peroral (500 µg). This new marketing authorization for the oral form of selenium comes in addition to the previous approval by the Central American country of selenase 500 μg injection solution. These pharmaceuticals are indicated to treat clinically proven selenium deficiency that cannot be compensated by nutritional sources.

Read more...